All In MedTech

FDA Clearance Tracker · P100034-S033

Optune Gio

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 30, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 30, 2024

Approved

Time to decision

350 days

Received Nov 15, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100034-S033
Device name
Optune Gio
Applicant location
Baar
Received
Nov 15, 2023
Decided
Oct 30, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100034

Device type

Device class
Class III

Every decision under product code NZK

FDA's approval statement

As written in FDA's record.

approval for the new Optune HFE Transducer Arrays and the NovoTAL flex software, which generates layout maps for the placement of the Optune HFE Transducer Arrays on the patient's head

Source documents

Other decisions for Novocure, GmbH

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.